Yiqun Bian1,2, Hao Wang3, Shui Sun4. 1. a Shandong University , Jinan , People's Republic of China. 2. b Liaocheng People's Hospital , Liaocheng , People's Republic of China. 3. c Hospital of Traditional Chinese Medicine of Liaocheng City , Liaocheng , People's Republic of China. 4. d Shandong Provincial Hospital , Jinan , People's Republic of China.
Abstract
Osteoarthritis (OA), characterized by pain and stiffness, swelling, deformity and dysfunction of joints, affects large numbers of population. The purpose of this study was to discover the effects of taurine in human OA chondrocytes and explore the underlying mechanisms. 46 patients with different grades of OA were recruited. Of these patients, 24 underwent total knee replacement and cartilages were harvested. The mRNA expressions of type II collagen (Collagen II) and endoplasmic reticulum (ER) stress markers (GRP78, GADD153 and Caspase-12) in cartilages were quantified by qRT-PCR. Cell viability and apoptosis of patient-derived chondrocytes were assessed by the CCK-8 assay and flow cytometry assay, respectively. Meanwhile, protein levels of Collagen II and ER stress markers both in cartilages and chondrocytes were evaluated by Western blot. The mRNA and protein levels of Collagen II decreased as OA progressed, while the expressions of ER stress markers increased dramatically. H2O2 induced ER stress in chondrocytes, as shown by the significant increase in the expression of ER stress markers, inhibited chondrocyte viability and Collagen II synthesis, promoted apoptosis. However, taurine treatment inhibited these above phenomena. These results indicated that taurine exhibited anti-OA effect by alleviating H2O2 induced ER stress and subsequently inhibiting chondrocyte apoptosis.
Osteoarthritis (OA), characterized by pain and stiffness, swelling, deformity and dysfunction of joints, affects large numbers of population. The purpose of this study was to discover the effects of taurine in human OA chondrocytes and explore the underlying mechanisms. 46 patients with different grades of OA were recruited. Of these patients, 24 underwent total knee replacement and cartilages were harvested. The mRNA expressions of type II collagen (Collagen II) and endoplasmic reticulum (ER) stress markers (GRP78, GADD153 and Caspase-12) in cartilages were quantified by qRT-PCR. Cell viability and apoptosis of patient-derived chondrocytes were assessed by the CCK-8 assay and flow cytometry assay, respectively. Meanwhile, protein levels of Collagen II and ER stress markers both in cartilages and chondrocytes were evaluated by Western blot. The mRNA and protein levels of Collagen II decreased as OA progressed, while the expressions of ER stress markers increased dramatically. H2O2 induced ER stress in chondrocytes, as shown by the significant increase in the expression of ER stress markers, inhibited chondrocyte viability and Collagen II synthesis, promoted apoptosis. However, taurine treatment inhibited these above phenomena. These results indicated that taurine exhibited anti-OA effect by alleviating H2O2 induced ER stress and subsequently inhibiting chondrocyte apoptosis.
Entities:
Keywords:
ER stress; H2O2; Taurine; anti-apoptosis; osteoarthritis
Osteoarthritis (OA), a common chronic disease that affects the joints, can be caused
by aging, mechanical injury, overweight, obesity and impairment of peripheral nerves
[1,2]. The clinical manifestations of OA contain articular
cartilage degradation and subchondral bone sclerosis, which may lead to joint
stiffness, deformity and dysfunction [3].
Chondrocytes, the only cells existing in articular cartilage, can generate and
maintain the articular cartilaginous matrix, which is composed mainly of collagen
and proteoglycans [4]. Recent reports
have demonstrated that elevated chondrocyte loss caused by apoptosis is a major
feature of OA [5,6].Endoplasmic reticulum (ER) stress, which occurs due to an imbalance between the load
of unfolded or misfolded proteins in the ER and the processing capacity of ER,
participates in many disease pathologies [6,7]. Recent studies have
demonstrated that ER stress in chondrocytes is responsible for chondrocyte apoptosis
along with the progression of OA [4,8,9].Taurine, first isolated and characterized from the bile of the ox, is one of the most
abundant endogenous free amino acids in humans [10]. It has been implicated in several essential biological processes
including bile acid conjugation, calcium modulation, osmoregulation, membrane
stabilization and protein phosphorylation. Moreover, anti-apoptosis and anti-oxidant
properties are essential for the cytoprotective functions of taurine [11,12]. Previous studies have confirmed that taurine inhibits ER
stress-induced apoptosis and protects against lung injury, stroke and
neurodegenerative diseases [11,13].However, no study has been done to examine the possible protective functions of
taurine on human OA yet. Therefore, we made a hypothesis that taurine treatment
might protect against OA by attenuating ER stress-associated apoptosis. To identify
that, cartilages were isolated from 24 OA patients who received total knee
replacement. The mRNA and protein levels of type II collagen (Collagen II),
glucose-regulated protein 78 (GRP78), growth arrest and DNA-damage inducible gene
153 (GADD153) and Caspase-12 in cartilages from patients with different OA grades
were quantified by qRT-PCR and Western blot analysis, respectively. OA
patient-derived chondrocytes were cultured in three conditions including: No
treatment (Control group), H2O2 treatment to induce ER stress
(H2O2 group) and preincubation with taurine before
H2O2 exposure
(H2O2 + taurine group). The viability and
apoptosis of cultured human OA chondrocytes were assessed by the CCK-8 assay and
flow cytometry assay, respectively. Meanwhile, Western blot was also employed to
evaluate the protein levels of Collagen II and ER stress markers in chondrocytes
with different treatments. Our results illustrated that ER stress is highly involved
in the H2O2-induced apoptosis in chondrocytes. Moreover, these
results for the first time established that taurine alleviated ER stress in human OA
chondrocytes, as shown by the significant decrease in the expressions of ER stress
markers, promoted chondrocyte viability and Collagen II synthesis, and inhibited
chondrocyte apoptosis.
Methods & materials
Ethical considerations
All experiments and procedures were reviewed and approved by the institutional
ethical review board of Liaocheng People’s Hospital, China. All the
participants were informed of the purpose of this study and provided informed
written consent.
Patients
Based on the American College of Rheumatology criteria, a total of 46 patients
diagnosed with OA in the Department of Orthopaedic Surgery at the Liaocheng
People’s Hospital between February 2012 and May 2017
(n = 46, 23 females and 23 males) were
enrolled in this study. Inclusion criteria specified men and non-pregnant women,
age 18–70 years, with primary OA of at least one knee. Primary OA was
defined by deterioration and abrasion of articular cartilage (joint space
narrowing) or formation of new bone (osteophytes) at the joint surface of the
knee (medial tibio-femoral, lateral tibio-femoral or patello-femoral),
demonstrated on a radiological examination carried out within the previous 3
months. Knees of OA patients were examined by clinical and radiological
evaluations and subsequently subdivided into 3 groups (grades I, II and III)
according to the degree of cartilage degeneration based on the
Kellgren–Lawrence radiographic grading scale (Figure 1) [14]. Of these patients, 24 underwent total knee replacement and
articular cartilage samples of them were collected
(n = 24, 12 females and 12 males, aged
between 18 and 65 years).
Figure
1.
Representative radiographs of patients with
different OA grades. Radiographs II
(n = 22) and III
(n = 15) demonstrated the
degenerative changes of OA while radiographs I
(n = 9) illustrated a
preserved joint space.
Representative radiographs of patients with
different OA grades. Radiographs II
(n = 22) and III
(n = 15) demonstrated the
degenerative changes of OA while radiographs I
(n = 9) illustrated a
preserved joint space.The following exclusion criteria was applied to the entire cohort: rheumatoid
arthritis (RA) or other inflammatory arthritis (including psoriatic arthritis,
post-infectious arthritis and metabolic arthritis, traumatic arthritis or
surgical joint replacement), defined as self-report of a physician diagnosis;
corticosteroid use or ever use of any RA-specific prescription medications;
unlikely to demonstrate measurable loss of joints space during the study,
defined as severe joint space narrowing on the baseline fixed flexion knees
radiograph; hepatic or peptic ulcer disease; history of alcohol or drug abuse;
lactation; concomitant skin disease at the application site; fibromyalgia; other
painful or disabling condition affecting the knee; other serious diseases, such
as cancer, stroke, and so on.
Specimen processing
Harvested cartilages were rinsed in PBS. In a sterile state, several frozen
cartilages of grade I, II and III were separately minced into small pieces.
Pieces of the tissues were used for protein extraction and total RNA extraction,
and the remaining samples were kept at −70°C.
OA patient-derived chondrocyte culture
Following washing with PBS, harvested cartilage from 6 OA patients of grade II
was cut into small pieces and digested using 0.2% collagenase (Sigma, MO,
USA) at 37°C overnight. After digestion, the chondrocytes were collected by
a 200 µm filter, and cultured in Dulbecco’s modified
Eagle’s medium (DMEM; Gibco, Gaithersburg, USA) supplemented with
10% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA, USA),
100 U/ml penicillin, and 100 μg/ml streptomycin. Chondrocytes
were cultured in monolayer
(2 × 106 cells/well in 12 well plates) at
37°C in a 5% CO2 incubator and the medium were changed
every 3 days.When cell confluency was close to 90%, the adherent chondrocytes were
passaged following trypsinization (0.25% Trypsin-EDTA, 2-3 mins). Then
the cells were collected following the second passage and seeded at a density of
0.6 × 106 cells per well in 6 well
plates. The chondrocytes were subdivided into 3 groups: Control group (no
treatment), H2O2 group (treatment with 0.3 mM
H2O2 for 4 h on day 4 after seeding), and
H2O2 + taurine group (treatment
with 25 mM taurine for 24 h prior to H2O2
exposure).
Western blot analysis
To analyze the mechanisms of taurine in the treatment of OA, Western blot was
performed as previously described [15]. Cells or cartilages, which were frozen and ground to fine powder in
liquid nitrogen, were lysed in RIPA buffer containing 1% (v/v) mammalian
protease inhibitor. Following lysate clarification, protein concentrations were
determined. Subsequently, soluble lysates were boiled in 2% SDS sample
buffer for 5 min. Equivalent amounts of protein were separated on
SDS-PAGE and electroblotted onto a nitrocellulose membrane (Pierce, WI, USA).
After blocking, membranes were incubated with goat polyclonal antibodies against
Collagen II (1:500; Proteintech), GRP78 (1:1000; Abcam, Cambridge, MA, USA),
GADD153 (1:500; Cell Signaling Technology, Danvers, MA, USA) and Caspase-12
(1:2000; Cell Signaling Technology, USA). Following extensive washes, the
membranes were incubated with HRP-conjugated anti-goat secondary antibodies
(1:3000; Abcam, USA). The protein immuno- complex was visualized and analyzed
(relative to β-actin expression) using an ECL system (Pierce, USA).
RNA extraction and real-time quantitative PCR (qRT-PCR) analysis
Total RNA was prepared from patient cartilages using the TRIzol Reagent
(Invitrogen, USA) according to the manufacturer’s instructions. SYBR®
Premix Ex Taq™ II kit (TaKaRa, shanghai, China) was used to quantify the
expression levels of Collagen II, GRP78, GADD153 and Caspase-12 according to the
protocol provided. Relative expression of above genes was measured by the
2−ΔΔCt method. The first ΔCT was the
difference in threshold cycle between the target and reference genes, and the
ΔΔCT was the difference in ΔCT as described in the above
between the target and reference samples, which was
ΔΔCT = ΔCT(a target
sample) − ΔCT(a reference sample). The final result of
this method was presented as the fold change of target gene expression in a
target sample relative to a reference sample, normalized to a reference gene. In
this study, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as
reference gene. All reactions were performed in triplicate. All primers were
listed as below:Collagen
IIForward 5′-CCA
CAC TCA ATC CCT CAA C-3′Reverse 5′-GCT GCT CCA CCA GTT CTT
C-3′;GRP78Forward
5′-TCC TAT GTC GCC TTC ACT-3′Reverse 5′-ACA GAC GGG TCA TTC
CAC-3′;GADD153Forward
5′-CTG ACC AGG GAA GTA GAG G-3′Reverse 5′-TGC GTA TGT GGG ATT
GAG-3′;Caspase-12Forward 5′-AAT CTG TGG GAC CAA
GCA-3′Reverse
5′-GAG CCT TTG TAA CAG CAT
CA-3′;GAPDHForward
5′-ACC CAG AAG ACT GTG GAC TT-3′Reverse 5′-TTC TAG ACG GCA GGT CAG
GT-3′.
CCK-8 assay
Cell viability and number was analyzed using CCK-8 solution (Promega, Beijing,
China) in accordance with the manufacturer’s instructions. Cells
(1 × 104/well) were seeded in three replicate
wells on a 96-well plate and treated with 20 μL/well of CCK-8 solution
for 4 h at 37°C. The absorbance at 490 nm was measured via a
microplate reader (Bio-Rad, Hercules, CA, USA). All reactions were performed in
triplicate.
Flow cytometry assay
Annexin V-FITC/propidium iodide (PI) double staining was used to quantify
apoptosis. In brief, chondrocytes were collected and stained with Annexin V-FITC
solution and PI in the dark for 15 min at room temperature. Subsequently,
cells were washed and resuspended in binding buffer. Stained cells were analyzed
by FACScan flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). Cells
incubated with binding buffer alone were set as negative control samples.
Statistical analysis
The data are presented as the means ± SEM. One-way ANOVA
followed by a Tukey’s post hoc test was used to analyze significant
differences between treatment groups. All the statistical analyses were
performed by SPSS software 13.0 and statistical significance was defined as a
p-value < 0.05, <0.01 or <0.001.
Results
The expressions of Collagen II and ER stress markers in the cartilage of OA
patients associated with the severity of OA progression
Compared with grade I, the levels of Collagen II mRNA were decreased
significantly in grades II (Figure 2(a),
p < 0.05) and III (Figure 2(a), p < 0.01).
In contrast, the mRNA levels of GADD153 and Caspase-12 were increased
dramatically in grades II (Figure 2(a),
p < 0.01) and III (Figure 2(a),
p < 0.001), as compared with grade
I. Moreover, both GADD153 and Caspase-12 mRNA levels in grade III were
significantly higher than those in grade II (Figure 2(a), p < 0.01). There was
no significant difference between grades I and II in GRP78 mRNA expression.
However, the GRP78 mRNA level increased obviously in grade III compared with
that in grade I (Figure 2(a),
p < 0.05).
Figure
2.
The expression of Collagen II, GRP78, GADD153 and
Caspase-12 in cartilages from patients with different OA grades. (a)
mRNA and (b) protein expressions of Collagen II and ER stress
markers were determined via qRT-PCR analysis and Western blot
analysis, respectively. (c) was the statistical analysis of (b).
Data were presented as mean ± SEM. Experiments
were repeated in triplicate.
*p < 0.05,
**p < 0.01 and
***p < 0.001
compared to grade
I. #p < 0.05 and
##p < 0.01compared to
grade II.
The expression of Collagen II, GRP78, GADD153 and
Caspase-12 in cartilages from patients with different OA grades. (a)
mRNA and (b) protein expressions of Collagen II and ER stress
markers were determined via qRT-PCR analysis and Western blot
analysis, respectively. (c) was the statistical analysis of (b).
Data were presented as mean ± SEM. Experiments
were repeated in triplicate.
*p < 0.05,
**p < 0.01 and
***p < 0.001
compared to grade
I. #p < 0.05 and
##p < 0.01compared to
grade II.As for gene expression, Collagen II protein levels were decreased dramatically in
grades II (Figure 2(b) and (c),
p < 0.05) and III (Figure 2(b) and (c),
p < 0.01), as compared to grade
I. Moreover, Collagen II protein level in grade III was significantly lower
than in grade II (Figure 2(b) and (c),
p < 0.05). In the case of GADD153 and
Caspase-12, protein expression levels were increased dramatically in grades II
(Figure 2(b) and (c),
p < 0.01) and III (Figure 2(b) and (c),
p < 0.001), as compared with grade
I. Moreover, both GADD153 and Caspase-12 protein levels in grade III were
dramatically higher than those in grade II (Figure 2(b) and (c), p < 0.01). Figure 2b and c also indicated that the
GRP78 protein abundance increased gradually with the severity of OA.
0.3 mM H2O2 and 25 mM taurine were chosen
for the subsequent experiments
The chondrocytes from OA patients were treated with H2O2 at
various concentrations (0–2 mM) for 4 h. The results showed
that the survival rate of chondrocytes decreased with the increasing of
H2O2 concentrations (Figure 3(a)), which indicated that H2O2
administration decreased the chondrocyte viability in a dose-dependent manner.
Compared with the control group, exposure to 0.3 mM
H2O2 for 4 h led to dramatic cytotoxicity and
approximately 60% of the chondrocytes remained viable (Figure 3(a),
p < 0.01). At 0.4, 0.5, 1 and 2 mM
H2O2 for 4 h, the survival rate of chondrocytes
decreased to 42%, 33%, 23% and 11%, respectively,
compared with the control group (Figure
3(a)). Thus, 0.3 mM H2O2 was chosen for
the subsequent experiments.
Figure
3.
Concentration dependent toxicity of taurine
and H2O2. Effects of (a)
H2O2 (0.1, 0.2, 0.3, 0.4, 0.5, 1 and
2 mM) and (b) taurine (5, 10, 15, 20, 25, 30, 35 mM)
on the cell viability of OA patient-derived chondrocytes were
measured via CCK-8 assay. Data were presented as
mean ± SEM.
*p < 0.05,
**p < 0.01 and
***p < 0.001
compared to control.
Concentration dependent toxicity of taurine
and H2O2. Effects of (a)
H2O2 (0.1, 0.2, 0.3, 0.4, 0.5, 1 and
2 mM) and (b) taurine (5, 10, 15, 20, 25, 30, 35 mM)
on the cell viability of OA patient-derived chondrocytes were
measured via CCK-8 assay. Data were presented as
mean ± SEM.
*p < 0.05,
**p < 0.01 and
***p < 0.001
compared to control.Chondrocytes were treated with 0–35 mM taurine for 24 h, and
the data showed that 0–25 mM taurine had no apparent effect on
chondrocyte viability (Figure 3(b)),
while 30 mM (Figure 3(b),
p < 0.05) or 35 mM (Figure 3(b),
p < 0.01) taurine resulted in significant
reduction in the survival percentage of chondrocytes. Thus, 25 mM taurine
was chosen for the subsequent experiments.
Taurine protected chondrocytes against damage induced by
H2O2 in vitro
To examine the effects of taurine on H2O2-stimulated
chondrocytes, CCK-8 assay and Annexin V-FITC/PI double binding assay were used
to measure the viability and apoptosis of chondrocytes, respectively. As shown
in Figure 4(a),
H2O2-induced oxidative stress in chondrocytes resulted
in a markable reduction in cell viability at day 7
(p < 0.01 or
p < 0.001). The impaired cell viability was
significantly recovered by taurine treatment
(p < 0.05) (Figure 4(a)).
Figure
4.
Taurine treatment affected the viability and
apoptosis of H2O2-stimulated chondrocytes. (a)
chondrocyte viability was measured by the CCK-8 assay. (b),
statistical bar graph showing the apoptosis ratio. (c), chondrocytes
were stained with Annexin V/propidium iodide and analyzed by
flow cytometry. Data were presented as
mean ± SEM. Experiments were repeated in
triplicate. *p < 0.05,
**p < 0.01 and
***p < 0.001
compared to control. #p < 0.05
and ##p < 0.01compared to
the H2O2
group.
Taurine treatment affected the viability and
apoptosis of H2O2-stimulated chondrocytes. (a)
chondrocyte viability was measured by the CCK-8 assay. (b),
statistical bar graph showing the apoptosis ratio. (c), chondrocytes
were stained with Annexin V/propidium iodide and analyzed by
flow cytometry. Data were presented as
mean ± SEM. Experiments were repeated in
triplicate. *p < 0.05,
**p < 0.01 and
***p < 0.001
compared to control. #p < 0.05
and ##p < 0.01compared to
the H2O2
group.As for cell apoptosis (Figure 4(b) and
(c)), showed that the apoptotic cell number of the
H2O2 + taurine group was significantly
lower than that of the H2O2 group, which indicated that
preincubation with taurine had a protective effect by reducing or inhibiting the
apoptosis of H2O2-treated chondrocytes.
Taurine inhibited ER stress induced by H2O2 stimulation
in human OA chondrocytes
To explore the inhibitory effects of taurine on ER stress-mediated apoptosis, we
measured the protein levels of Collagen II and three ER stress markers. Under
normal condition, there were lots of Collagen II in the chondrocytes.
H2O2 stimulation dramatically decreased the protein
abundance of Collagen II by nearly 73% (Figure 5(a) and (b), p < 0.01),
compared to the control group. However, taurine treatment significantly
increased the abundance of Collagen II by 100% (Figure 5(a) and (b),
p < 0.05), compared to the
H2O2 group.
Figure
5.
Taurine treatment affected the expressions of
Collagen II, GRP78, GADD153 and Caspase-12 in
H2O2-treated chondrocytes. (a)Western blot
were used to assay the protein expressions and β-actin was used
as a loading control. (b) was the statistical analysis of (a). Data
were presented as mean ± SEM. Experiments were
repeated in triplicate.
*p < 0.05,
**p < 0.01 and
***p < 0.001
compared to control. #p < 0.05
and ##p < 0.01 compared to
the H2O2
group.
Taurine treatment affected the expressions of
Collagen II, GRP78, GADD153 and Caspase-12 in
H2O2-treated chondrocytes. (a)Western blot
were used to assay the protein expressions and β-actin was used
as a loading control. (b) was the statistical analysis of (a). Data
were presented as mean ± SEM. Experiments were
repeated in triplicate.
*p < 0.05,
**p < 0.01 and
***p < 0.001
compared to control. #p < 0.05
and ##p < 0.01 compared to
the H2O2
group.The results of Western blot also showed that GRP78, GADD153 and Caspase-12 were
hardly expressed in human OA chondrocytes under normal conditions (Figure 5(a) and (b)). The stimulation of
H2O2 significantly enhanced the expressions of all
three ER stress markers (Figure 5(a) and
(b), p < 0.001). Interestingly, taurine
treatment significantly inhibited these phenomena (Figure 5(a) and (b),
p < 0.01).
Discussion
OA, caused by abnormal mechanical stress loaded on the cartilages and low level
inflammatory processes, is one of the serious concerns to the health of human beings
and will ultimately result in joint degeneration, or even disability [16]. Previous studies have indicated that
elevated chondrocyte apoptosis, which is associated with the degradation of
cartilage matrix, is the hallmark of OA and chondrocyte apoptosis inhibition is
vital for the treatment of OA [17,18].ER, a key organelle, participates in the processes of protein synthesis, modification
and secretion and is vital for cell survival and function [19,20].
Perturbations of intracellular calcium homeostasis cause the accumulation of
misfolded and/or unfolded proteins in the ER, leading to a state known as ER stress.
ER stress has been reported to be involved in ischemia reperfusion, diabetes
mellitus, liver disease, kidney disease and neuro- degenerative disease [13,21-24]. In addition, a large
number of studies have proved that ER stress is also associated with chondrocyte
death by apoptosis in vivo and in vitro [6,14].In this study, a total of 46 OA patients were recruited and patient cartilages were
collected from 24 patients undergoing total knee replacement surgery. The mRNA and
protein expressions of Collagen II and ER markers, such as GRP78, GADD153 and
Caspase-12, were detected by qRT-PCR analysis and Western blot analysis,
respectively. X-ray of grade III cartilage showed cartilage disappearance and marked
joint space narrowing (Figure 1), and the
mRNA and protein levels of Collagen II gradually decreased as OA progressed.
Furthermore, the mRNA and protein expressions of the above ER markers, which were
specific for ER stress, increased dramatically as cartilage degeneration worsened.
Thus, the above results indicated that ER stress played a crucial role in the
development of OA, which was consisted with previous reports [15].Taurine, one of the abundant amino acids existing in mammalian tissues, can resist
various types of damages by its anti-oxidant and anti-apoptosis activities in both
clinical trials and animal studies [25-28]. Taurine could not
only promote cell growth and maintain phenotype of human articular chondrocytes
[29], but also ameliorate ROS-induced
cartilage damage through its antioxidant property [15,30]. It is
worth noting that a significant increase in NRF2 mRNA levels in the
H2O2-stimulated chondrocyte is observed after treatment
with taurine at a low concentration of 200 μM [31]. Whether such transcriptional regulation is lying
behind alleviation of ER stress needs further research .Another thing needs more
concern is the dose variability, which is relative common in clinical practice. The
dose varies from 120 to 480 μM [31,32], while in our study
the concentration of 25 mM taurine is the critical concentration which will
do no apparent harm to chondrocyte viability. Such concentration is chosen to show
the best characteristics its alleviation to ER stress.It is known that an increase in Reactive oxygen species (ROS), including hydrogen
peroxide (H2O2), superoxide
()
and hydroxyl radical (·OH), impairs intracellular calcium homeostasis and
subsequently results in ER stress [33].
Pan et al. (2010) found that
H2O2 increased oxidative stress and up-regulated the
expressions of GRP-78 and GADD153 in rat phenocromocytoma PC12 cells [34]. Banerjee et al. (2017) reported that that andrographolide
treatment induced ROS production in colon cancer cells and that elevated ROS caused
ER stress, which subsequently inducing cell apoptosis process [33]. In order to examine whether taurine exerted
cytoprotective effects against H2O2 induced oxidative stress
related to ER stress, Western blot analysis was employed to assay the protein levels
of Collagen II and three ER stress markers. According to the results,
H2O2 stimulation significantly enhanced the protein
abundances of ER stress markers, which indicated the induction of ER stress by
H2O2-stimulated oxidative stress, and taurine
administration significantly inhibited these phenomena. In addition, taurine
administration also prevented the decrease in Collagen II protein level by
H2O2 treatment. Taken together, the above data provided
compelling evidence that taurine had cytoprotective effects against
H2O2 induced ER stress by promoting chondrocyte viability
and inhibiting apoptosis.In conclusion, our study demonstrated that the use of taurine had anti-apoptotic
effects on OA patient-derived chondrocytes stimulated with
H2O2. Taurine treatment promoted chondrocyte viability and
inhibited chondrocyte apoptosis by suppressing the ER stress pathway, as evidenced
by the up-regulation of the expression of Collagen II and the down-regulation of the
expressions of ER stress markers. Thus, our results illustrated that taurine was a
promising OA therapeutic agent. In the other hand, it is well-known that ER stress
will further lead to the Unfolded Protein Response (UPR) in three major UPR signal
transduction pathways, including ATF6, PERK and IRE1 signaling pathways [34]. Hence, further studies are still
required to explore in detail which specific signaling pathway in ER was affected by
taurine treatment. Additionally, the question of how
H2O2-induced oxidative stress triggered ER stress remained
unanswered and further experiments are also needed to elucidate the precise
mechanisms responsible for the oxidative stress-elicited ER stress both in
vitro and in vivo.
Conclusion
This study provided solid evidence that taurine treatment exhibited anti-OA roles by
suppressing H2O2-induced apoptosis in cultured chondrocytes of
OA patients. The possible mechanism was that preincubation with 25 mM taurine
alleviated H2O2-induced ER stress in chondrocytes by
significantly inhibiting the expression of three ER stress markers and increasing
Collagen II synthesis. Thus, our study showed that taurine was a promising OA
therapeutic agent.
Authors: Sara Cheleschi; Anna De Palma; Nicola Antonio Pascarelli; Nicola Giordano; Mauro Galeazzi; Sara Tenti; Antonella Fioravanti Journal: Int J Mol Sci Date: 2017-12-08 Impact factor: 5.923
Authors: Larissa E van Eijk; Annette K Offringa; Maria-Elena Bernal; Arno R Bourgonje; Harry van Goor; Jan-Luuk Hillebrands Journal: Adv Exp Med Biol Date: 2022 Impact factor: 3.650
Authors: Katarzyna Kornicka; Mohamad Al Naem; Michael Röcken; Marta Zmiertka; Krzysztof Marycz Journal: J Clin Med Date: 2019-03-08 Impact factor: 4.241
Authors: Rebecca F Shepherd; Jemma G Kerns; Lakshminarayan R Ranganath; James A Gallagher; Adam M Taylor Journal: Calcif Tissue Int Date: 2021-08-21 Impact factor: 4.333
Authors: Elizabeth Pérez-Hernández; Jesús Javier Pastrana-Carballo; Fernando Gómez-Chávez; Ramesh C Gupta; Nury Pérez-Hernández Journal: Endocrinol Metab (Seoul) Date: 2022-08-08